Zobrazeno 1 - 10
of 2 447
pro vyhledávání: '"J. Schiller"'
Autor:
J. Schiller, T. Kellner, J. Briest, K. Hoepner, A. Woyciechowski, A. Ostermann, C. Korallus, C. Sturm, T. Weiberlenn, L. Jiang, C. Egen, F. Beissner, M. Stiesch, M. Karst, C. Gutenbrunner, M. G. Fink
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-11 (2019)
Abstract Background This study aims to evaluate the feasibility and efficacy of a complex health intervention, based on the combination of conventional Western medicine and traditional Chinese medicine (TCM), in an outpatient department of a universi
Externí odkaz:
https://doaj.org/article/1db52af834cc43e5bf0c577cee893b48
Publikováno v:
Travmatologiâ i Ortopediâ Rossii, Vol 0, Iss 1, Pp 24-33 (2016)
«Frozen shoulder» is a common problem and difficult to treat. The present prospective randomised single-blind controlled trial evaluates the efficacy of the fascial distortion model according to Typaldos as a remedy for the «frozen shoulder». Mat
Externí odkaz:
https://doaj.org/article/5365773caa4f4a8aa6dcdcacc26bb26e
Autor:
Beth K. Neilsen, MD, PhD, Richard L. Sleightholm, MD, PhD, MPH, Arjan Gower, MD, MS, Steven C. Tsai, MD, PhD, Gary J. Schiller, MD, Caspian Oliai, MD, MS, Alan Lee, MD, Ann Raldow, MD, MPH, Stephen Tenn, PhD, Puja S. Venkat, MD
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 7, Pp 101506- (2024)
Externí odkaz:
https://doaj.org/article/f8587ac912dd483b81de7776f28bbba7
Autor:
Darrell White, Gary J. Schiller, Sumit Madan, Suzanne Lentzsch, Evgeni Chubar, Noa Lavi, Dane R. Van Domelen, Ohad S. Bentur, Muhamed Baljevic
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
ObjectiveTo identify the optimal dose of selinexor in combination with pomalidomide and dexamethasone (SPd).MethodsAn analysis of efficacy and safety of 2 once-weekly selinexor regimens (60 mg and 40 mg) with pomalidomide and dexamethasone (SPd-60 an
Externí odkaz:
https://doaj.org/article/faf3645ed4d642638bc528022e510fa6
Publikováno v:
Global Qualitative Nursing Research, Vol 11 (2024)
Medical Assistance in Dying (MAID) legislation has evolved rapidly in Canada with significant impacts on nursing practice. The purpose of this paper is to describe evolving complexities in legislative context and practice standards that influence the
Externí odkaz:
https://doaj.org/article/bc6c496d738b452a92b7ad6dc7a2cde7
Autor:
J. Schiller, M. Faber
Publikováno v:
Technikfolgenabschätzung – Theorie und Praxis, Vol 8, Iss 1 (1999)
Externí odkaz:
https://doaj.org/article/b492e833b19e463f9e7b9285cc7bbe29
Autor:
Kathleen Leslie, Sophia Myles, Abeer A. Alraja, Patrick Chiu, Catharine J. Schiller, Sioban Nelson, Tracey L. Adams
Publikováno v:
PLoS ONE, Vol 19, Iss 5 (2024)
Externí odkaz:
https://doaj.org/article/8e150cf0a9574dde9010495177b492eb
Autor:
H. Cliff Sullivan, Manish J. Gandhi, Sujata Gaitonde, Ramya Narasimhan, Ketevan Gendzekhadze, Soumya Pandey, Rhonda K. Roby, George C. Maha, Harmeet Kaur, Jennifer J. Schiller, Julie McDowell, Maria Smith, Chang Liu, Gerald P. Morris
Publikováno v:
Frontiers in Genetics, Vol 14 (2023)
The Histocompatibility and Identity Testing Committee offers an overview of the College of American Pathologists’ (CAP) Proficiency Testing (PT) program, commemorating its significant 75th anniversary in 2024. The CAP PT program has undergone signi
Externí odkaz:
https://doaj.org/article/a402636f0a95461e875835d443726499
Autor:
Muhamed Baljevic, Cristina Gasparetto, Gary J. Schiller, Sascha A. Tuchman, Natalie S. Callander, Suzanne Lentzsch, Jorge Monge, Rami Kotb, Nizar J. Bahlis, Darrell White, Christine I. Chen, Heather J. Sutherland, Sumit Madan, Richard LeBlanc, Michael Sebag, Christopher P. Venner, William I. Bensinger, Noa Biran, Andrew DeCastro, Dane R. Van Domelen, Chris Zhang, Jatin J. Shah, Sharon Shacham, Michael G. Kauffman, Ohad S. Bentur, Brea Lipe
Publikováno v:
eJHaem, Vol 3, Iss 4, Pp 1270-1276 (2022)
Abstract There is a lack of consensus on therapy sequencing in previously treated multiple myeloma, particularly after anti‐B‐cell maturation antigen (BCMA) therapy. Earlier reports on selinexor (X) regimens demonstrated considerable efficacy in
Externí odkaz:
https://doaj.org/article/cc625c53f2e041649d56e52c14f79586
Autor:
Daniel J DeAngelo, Yi Lin, Roch Houot, Marion Subklewe, Petra C Schuberth, Michael R Bishop, Nicolas Boissel, Dimitrios Tzachanis, Jae H Park, Monique C Minnema, Thibaut Leguay, Mehrdad Abedi, Bijal D Shah, Ryan D Cassaday, Olalekan O Oluwole, Aaron C Logan, Max S Topp, Kristen M O'Dwyer, Martha L Arellano, Maria R Baer, Gary J Schiller, William G Wierda, Patrick J Stiff, Deepa Jeyakumar, Daqin Mao, Sabina Adhikary, Lang Zhou, Rita Damico Khalid, Armin Ghobadia
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 8 (2023)
Background Brexucabtagene autoleucel (brexu-cel) is an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy approved in the USA for adults with relapsed or refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL) and in the Europea
Externí odkaz:
https://doaj.org/article/6d2eb34905f7419ca7f3a7451cc9953e